Plunkett Research Online: Caladrius Biosciences Inc

CALADRIUS BIOSCIENCES INC (CLBS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Caladrius Biosciences Inc is a biopharmaceutical company. It develops novel proprietary cell therapy products. It is engaged in the preservation & enhancement of human health through the development of cell based therapeutics......

Caladrius Biosciences Inc
Ticker: CLBS
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 212-584-4180
Fax: 646-514-7787
Address: 110 Allen Road
2nd Floor
Basking Ridge, NJ 07920 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Stem Cell Processing
Contract Research & Development
Drug Discovery & Development
Contacts Description

Joseph Talamo CFO/Chief Accounting Officer/Senior VP
Gregory Brown Chairman of the Board/Director
See More

Auditor: Grant Thornton LLP
Legal Advisor: Lowenstein Sandler PC
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Progenitor Cell Therapy LLC
Amorcyte LLC
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: